“…Much efforts in continuous crystallisation have focused on small organic pharmaceuticals (Baxendale et al, 2015;McGlone et al, 2015). However, knowledge of oscillatory flow crystallisation, like mixing condition (Chew et al, 2004;Yang et al, 2016), nucleation (Yang et al, 2016), growth (Brown and Ni, 2011), process control (Briggs et al, 2015) on small organic pharmaceutical molecules can also help to develop and design protein continuous crystallisation process. However, the differences between crystallisation of proteins with small organic molecules are obvious.…”